Skip to main content

Advertisement

Log in

Management of acute mitochondriopathy and encephalopathy syndrome in pediatric intensive care unite: a new clinical entity

  • Original article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Acute mitochondriopathy and encephalopathy syndrome (AMES) is described differently by different authors in the literature. As a new clinical entity, we aimed to present the clinical signs and symptoms, diagnosis and treatment algorithm of our patients with AMES. 56 patients aged between 2 months and 18 years who were followed up in pediatric intensive care units of Konya Training and Research Hospital and Selcuk University Medical Faculty Hospital, between January 2010 and June 2017 were included. Patients’ data were obtained retrospectively from the intensive care unit patient files. 34 (60.7%) of the patients were male and 22 (39.3%) were female. The median age of our patients was 10.0 months. At the time of admission, 42 (75%) of the patients had fever, 35 (62.5%) vomiting, 27 (48.2%) abnormal behaviour and agitation and 28 (50%) convulsion. The etiological classification of patients with AMES was divided into four groups as infection, metabolic disorder, toxic, and hypoxic-ischemic. 39 (69.6%) patients were found to have infection, 10 (17.9%) patients hypoxia, 7 (12.5%) patients metabolic disorders. AMES occurs rarely, but should be kept in mind in the differential diagnosis of patients with any encephalopathy of unknown origin especially in those with a history of ingestion of drugs, previous viral infection and vomiting. Early recognition and treatment is imperative to reduce morbidity and mortality in children with AMES.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Reye RDK, Morgan G, Baral J (1963) Encephalopathy and fatty degeneration of the viscera: a disease entity in childhood. Lancet 2:749–752

    Article  CAS  Google Scholar 

  2. Brain WR, Hunter D, Turnbull HM (1929) Acute meningo-encephalomyelitis of childhood: report of 6 cases. Lancet 1:221–227

    Article  Google Scholar 

  3. Waldman RJ, Hall WN, McGee H, van Amburg G (1982) Aspirin as a risk factor in Reye’s syndrome. J Am Med Ass 247:3089–3094

    Article  CAS  Google Scholar 

  4. Orlowski JP, Gillis J, Kilham HA (1987) A catch in the Reye. Pediatrics 80:638–642

    CAS  PubMed  Google Scholar 

  5. Smith TCG (1996) Reye’s syndrome and the use of aspirin. Scott Med J 41:4–8

    Article  CAS  Google Scholar 

  6. Schror K (2007) Aspirin and Reye syndrome: a review of the evidence. Pediatr Drugs 9:195–204

    Article  Google Scholar 

  7. Devulapalli CS (2000) Rotavirus gastroenteritis possibly causing Reye syndrome. Acta Pediatr 89:613–619

    Article  CAS  Google Scholar 

  8. Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M (2007) Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand Suppl 186:45–56

    Article  CAS  Google Scholar 

  9. Leonard JV, Schapira AHV (2000) Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. The Lancet 355:299–304

    Article  CAS  Google Scholar 

  10. Starko KM, Ray CG, Dominguez LB, Stromberg WL, Woodall DF (1980) Reye’s syndrome and salicylate use. Pediatrics 66:859–864

    CAS  PubMed  Google Scholar 

  11. Baldellou Va`zquez A (2003) Reye’s syndrome. Forty years later. An Pediatr 59:319–322

    Article  CAS  Google Scholar 

  12. Glasgow JFT, Middelton B (2001) Reye syndrome-insights on causation and prognosis. Arch Dis Child 85:351–353

    Article  CAS  Google Scholar 

  13. Togashi T, Matsuzono Y, Itakura O, Narita M (1999) IL-6 and TNF-a in cerebrospinal fluid from infantile encephalitis encephalopathy patients during influenza seasons. J Jpn Pediatr Soc 103:16–19

    Google Scholar 

  14. Ichiyama T, Endo S, Kaneko M, Isumi H, Matsubara T, Furukawa S (2003) Serum cytokine concentrations of influenza associated acute necrotizing encephalopathy. Pediatr Int 45:734–736

    Article  CAS  Google Scholar 

  15. Morishima T (2003) Studies on the epidemiology and pathogenesis of encephalitis/encephalopathy occurring during the clinical course of influenza. In: 2000–2002 General Report of the Research Committee for Research on Emerging and Re-emerging Diseases. Ministry of Health, Labour and Welfare of Japan, Tokyo, pp 1–23 (in Japanese)

    Google Scholar 

  16. Weiner DL et al (2012) Medscape, Reye Syndrome

  17. Mohnike K, Starke I, Bannert N, Heise HR (1993) Differential diagnosis and therapy of hypoglycemia in childhood. Kinderarztl Prax 61:192–201

    CAS  PubMed  Google Scholar 

  18. Chang PF, Huang SF, Hwu WL, Hou JW, Ni YH, Chang MH (2000) Metabolic disorders mimicking Reye’s syndrome. J Formos Med Assoc 99:295–299

    CAS  PubMed  Google Scholar 

  19. Visentin M, Salmona M, Tacconi MT (1995) Reye’s and Reye-like syndromes, drug-related diseases? (causative agents, etiology, pathogenesis, and therapeutic approaches). Drug Metab Rev 27:517–539

    Article  CAS  Google Scholar 

  20. Gill RQ, Sterling RK (2001) Acute liver failure. J Clin Gastroenterol 33:191–198

    Article  CAS  Google Scholar 

  21. Wulur H, Kho LK (1990) Treatment of Reye’s syndrome at Sumber Waras Hospital. Acta Paediatr Jpn 32:435–442

    Article  CAS  Google Scholar 

  22. Brunner RL, O’Grady DJ, Partin JC, Partin JS, Schubert WK (1979) Neuropsychologic consequences of Reye syndrome. J Pediatr 95:706–711

    Article  CAS  Google Scholar 

  23. Devivo DC (1978) Reye syndrome: a metabolic response to an acute mitochondrial insult? Neurology 28:105–108

    Article  CAS  Google Scholar 

  24. Devivo DC, Keating JP (1976) Reye’s syndrome. Adv Pediatr 22:175–229

    CAS  PubMed  Google Scholar 

  25. Lemberg A, Fernández MA, Coll C, Rosello DO, Romay S, Perazzo JC et al (2009) Reyes’s syndrome, encephalopathy, hyperammonemia and acetyl salicylic acid ingestion in a city hospital of Buenos Aires, Argentina. Curr Drug Saf 4:17–21

    Article  CAS  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to revising critically the final version of the manuscript. Interpretation of data and revising of manuscript: ŞA, FA. Study conception and design: AY. Preparation of manuscript: AY, FA. Literature review: ŞA, Review and supervision of manuscript: AS.

Corresponding author

Correspondence to Alaaddin Yorulmaz.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

The ethics committee approval for the study was received from the ethical committee of Selcuk University (2018/01).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arslan, Ş., Yorulmaz, A., Sert, A. et al. Management of acute mitochondriopathy and encephalopathy syndrome in pediatric intensive care unite: a new clinical entity. Acta Neurol Belg 120, 1115–1121 (2020). https://doi.org/10.1007/s13760-019-01125-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-019-01125-3

Keywords

Navigation